Rebelatto, Marlon C <br/><br/>
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.  [electronic resource] 

 -  Diagnostic pathology  Oct 2016 
 - 95 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Validation Study 
<br/><br/><label>ISSN: </label>1746-1596 
<br/><br/><label>Standard No.: </label>10.1186/s13000-016-0545-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Area Under Curve<br/>B7-H1 Antigen--analysis<br/>Biomarkers, Tumor--analysis<br/>Carcinoma, Non-Small-Cell Lung--chemistry<br/>Carcinoma, Squamous Cell--chemistry<br/>Cell Line, Tumor<br/>Fixatives<br/>Formaldehyde<br/>HEK293 Cells<br/>Head and Neck Neoplasms--chemistry<br/>Humans<br/>Immunohistochemistry<br/>Laboratory Proficiency Testing<br/>Lung Neoplasms--chemistry<br/>Observer Variation<br/>Paraffin Embedding<br/>Predictive Value of Tests<br/>ROC Curve<br/>Reproducibility of Results<br/>Squamous Cell Carcinoma of Head and Neck<br/>Tissue Fixation--methods<br/>Transfection